SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001472375-22-000055
Filing Date
2022-06-28
Accepted
2022-06-28 15:23:23
Documents
51
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT FOR THE YEAR ENDED MARCH 31, 2022 ixform10k.htm   iXBRL 10-K 417558
2 CERTIFICATION exhibit31-1.htm EX-31.1 11030
3 CERTIFICATION exhibit31-2.htm EX-31.2 10992
4 CERTIFICATION exhibit32-1.htm EX-32.1 4228
5 CERTIFICATION exhibit32-2.htm EX-32.2 4218
6 regenerexlogo.gif GRAPHIC 5716
  Complete submission text file 0001472375-22-000055.txt   2339328

Data Files

Seq Description Document Type Size
7 SCHEMA DOCUMENT reg1357878-20220331.xsd EX-101.SCH 19860
8 CALCULATION LINKBASE DOCUMENT reg1357878-20220331_cal.xml EX-101.CAL 29540
9 DEFINITION LINKBASE DOCUMENT reg1357878-20220331_def.xml EX-101.DEF 40364
10 LABELS LINKBASE DOCUMENT reg1357878-20220331_lab.xml EX-101.LAB 163968
11 PRESENTATION LINKBASE DOCUMENT reg1357878-20220331_pre.xml EX-101.PRE 134431
45 EXTRACTED XBRL INSTANCE DOCUMENT ixform10k_htm.xml XML 220912
Mailing Address 5348 VEGAS DRIVE #177 LAS VEGAS NV 89108
Business Address 5348 VEGAS DRIVE #177 LAS VEGAS NV 89108 (702) 805-7525
REGENEREX PHARMA, INC. (Filer) CIK: 0001357878 (see all company filings)

IRS No.: 980479983 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 000-53230 | Film No.: 221049443
SIC: 2834 Pharmaceutical Preparations